31 active trials 17 recruiting 8 Phase 3 9 disease areas 10 changes in 30 days
6 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 3 with minor changes only.
Recruitment opened
Also in this update: Start date changed from estimate of Sep 30, 2026 to Sep 11, 2026
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 2 NCT07799688 Registry history of NCT07799688 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1 NCT07802964 Registry history of NCT07802964 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1 NCT07807059 Registry history of NCT07807059 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1 NCT07559136 Registry history of NCT07559136 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 8 participants (planned 64); Primary completion date changed from estimate of Dec 2025 to Oct 9, 2025
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 1 NCT07195604 Registry history of NCT07195604 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Jul 2026 to Sep 2026
Also in this update: Completion pushed from Aug 2026 to Oct 2026
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 2 NCT07318103 Registry history of NCT07318103 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-28 | NCT07843862 A Study of HRS-4729 Injection in Participants With Type 2 Diabetes | Phase 2 | Not Yet Recruiting |
| 2026-09-25 | NCT07841860 A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596… | Phase 1 | Not Yet Recruiting |
| Phase 1 | 9 | |
| Phase 2 | 14 | |
| Phase 3 | 8 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07551492 | A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With… | Atherosclerotic Cardiovascular Disease | Recruiting | 2026-09-08 |
| NCT07670884 | A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or… | Chronic Management of Body Weight | Recruiting | 2026-08-13 |
| NCT07606950 | Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients… | Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B | Recruiting | 2026-07-24 |
| NCT06994650 | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to… | Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy | Recruiting | 2026-01-26 |
| NCT07060456 | Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal… | Type 2 Diabetes | Recruiting | 2026-01-02 |
| NCT06974851 | A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects… | Bstructive Sleep Apnea (OSA) and Obesity | Recruiting | 2025-11-17 |
| NCT07709910 | A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis | Participants With Obesity and Knee Osteoarthritis | Not Yet Recruiting | 2026-07-17 |
| NCT07285902 | A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection… | Obesity | Active, Not Recruiting | 2026-02-27 |
| Phase 2 | ||||
| NCT07799688 | A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With… | Hyperlipidemia | Recruiting | 2026-10-09 |
| NCT07318103 | Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced… | Fluid Retention Caused by Heart Failure | Recruiting | 2026-09-16 |
| NCT07660848 | A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic… | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Recruiting | 2026-08-26 |
| NCT07709897 | A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for… | Prevention of Postoperative Nausea and Vomiting | Recruiting | 2026-08-26 |
| NCT07599410 | A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in… | T2DM | Recruiting | 2026-07-23 |
| NCT06425341 | A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and… | Chronic Hepatitis B | Recruiting | 2025-11-17 |
| NCT07843862 | A Study of HRS-4729 Injection in Participants With Type 2 Diabetes | Type 2 Diabetes | Not Yet Recruiting | 2026-09-28 |
| NCT07308392 | Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in… | Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis | Active, Not Recruiting | 2026-09-08 |
| NCT07297797 | Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension | Mild to Moderate Hypertension | Active, Not Recruiting | 2026-07-31 |
| NCT07690826 | A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity | Overweight or Obesity | Not Yet Recruiting | 2026-07-08 |
| NCT07233070 | HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. | Acute Ischemic Stroke | Active, Not Recruiting | 2026-06-29 |
| NCT07100418 | A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With… | Hyperlipidemia | Active, Not Recruiting | 2026-06-03 |
| NCT07185776 | A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for… | Lipoprotein Disorder | Active, Not Recruiting | 2026-03-05 |
| NCT06391710 | HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Active, Not Recruiting | 2025-11-24 |
| Phase 1 | ||||
| NCT07802964 | A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity… | Psoriasis Vulgaris | Recruiting | 2026-09-25 |
| NCT07807059 | A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and… | Overweight/Obesity | Recruiting | 2026-09-16 |
| NCT07540754 | A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild… | Diabetes Mellitus | Recruiting | 2026-06-01 |
Obesity (11) · Diabetes (6) · Type 2 Diabetes (6) · Heart Failure (3) · NASH / MASH (2) · Heart Disease (1) · Hypertension (1) · Psoriasis (1) · Stroke (1)